- What does THISX invest in?
- The fund's primary objective is to achieve long-term capital appreciation. To meet this goal, it typically invests at least 80% of its net assets (including any assets acquired through borrowing) in the common stocks of companies within the broad "health sciences" sector. This includes firms involved in the research, development, production, or distribution of products and services related to healthcare, medicine, or life sciences. While the fund maintains the flexibility to invest in companies of any size, the majority of its portfolio is expected to be allocated to large- and mid-capitalization companies.
- What is the expense ratio of THISX?
- T. Rowe Price Health Sciences Fund I Class (THISX) charges an expense ratio of 0.68%. This is the annual fee deducted from fund assets to cover management and operations.
- How big is THISX?
- T. Rowe Price Health Sciences Fund I Class (THISX) manages $12.03B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.
- Is THISX actively managed or an index fund?
- THISX is actively managed — the manager selects holdings rather than tracking an index. Active funds typically charge higher expense ratios than index funds (THISX's is 0.68%) in exchange for the discretion to over- or under-weight positions.
- When was THISX launched?
- T. Rowe Price Health Sciences Fund I Class (THISX) launched in March 2016 and is managed by T. Rowe Price.
- How has THISX performed?
- THISX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
